Augmedix stock falls 41% after it lowers FY24 revenue guidance

The company's stock price dropped after it released its first-quarter earnings and lowered its full-year guidance despite an increase in revenue.

from MobiHealthNews https://ift.tt/VNw2bqW
https://ift.tt/DLTKuMp